scorecardresearch
Pfizer

Pfizer

 

More Stories on Pfizer
The three contenders in the race are Pfizer and its rivals, Merck & Co Inc and Swiss pharmaceutical Roche Holding AG

Three pharma cos in race to find COVID-19 treatment pill; results likely by 2021-end

Sep 25, 2021

The medication being produced by Merck & Co. and Ridgeback Biotherapeutics is called molnupiravir, while two other candidates in the works are PF-07321332, and AT-527 by Pfizer and Roche and Atea Pharmaceuticlas

India's monthly domestic output has trebled since April and will reach 300 million doses in October, according to Health Minister Mansukh Mandaviya.

COVID-19: India to not buy Pfizer, Moderna vaccines as domestic output jumps

Sep 21, 2021

The Indian government has also declined to meet the U.S. companies' requests for legal protection over any side-effects from the use of their shots, two of the sources said.

The vaccine was around 95 percent effective in the adult clinical trial, but Pfizer has said that immunity wanes some months after the second dose

Clinical trial data shows Pfizer COVID-19 vaccine safe for kids

Sep 20, 2021

Pfizer and BioNtech SE said the vaccine generated an immune response in the 5-to-11 year olds in their Phase II/III clinical trial that matched what they had previously observed in 16-to-25 year olds

Earlier this month, Britain's Joint Committee on Vaccination and Immunization said vaccines should be given to 12- to 15-year-olds with underlying health conditions

UK okays vaccines for 12-15 year olds, looks to avert lockdowns

Sep 14, 2021

Vaccinations for children and booster shots for at-risk adults are expected to be part of a "tool kit" to control COVID-19 infections this fall and winter that Prime Minister Boris Johnson plans to announce Tuesday at a news conference

Covaxin in one of the vaccines being administered in the country under the nationwide vaccination programme against coronavirus.

WHO to approve Bharat Biotech's COVID-19 vaccine Covaxin this week: Report

Sep 13, 2021

So far, the WHO has approved COVID-19 vaccines of Pfizer-BioNTech, AstraZeneca-SK Bio or Serum Institute of India, Johnson & Johnson, Moderna, and Sinopharm.

Gottlieb said on the CBS show Face the Nation that in a best-case scenario, the Pfizer vaccine could be ready by October 31 for younger children

COVID-19 vaccine for 5-11 years age group likely to be out in US by October-end: Report

Sep 13, 2021

A report in The New York Times quoted two health experts as saying that COVID vaccines for children aged 5 to 11 could be available as soon as the end of October

Moderna's COVID-19 vaccine is significantly more effective against the Delta variant of the SARS-CoV2 virus than Pfizer or Johnson & Johnson, suggests a new study

Moderna's COVID-19 vaccine more effective against Delta variant than Pfizer, J&J, reveals study

Sep 11, 2021

Published in Morbidity and Mortality Weekly Report, the study indicates that Moderna was 95% effective at preventing hospitalisation among adults aged 18 years and older, while Pfizer was 80% effective and J&J was 60% effective

The FDA granted full approval last month for the use of Pfizer Inc's vaccine in people over the age of 16 based on a six-month follow-up from the trial. Photo: Reuters

US heath regulator may authorise COVID-19 vaccine for kids based on two months of safety data

Sep 10, 2021

The US Food and Drug Administration says it is looking to complete the data review as quickly as possible, likely in a matter of weeks rather than months

So far the Pfizer/BioNTech, Janssen and AstraZeneca vaccines have been provisionally approved by New Zealand authorities

New Zealand reports first death linked to Pfizer COVID-19 vaccine

Aug 30, 2021

“This is the first case in New Zealand where a death in the days following vaccination has been linked to the Pfizer COVID-19 vaccine,” the New Zealand health ministry said

mRNA vaccines present various benefits as they are non-infectious, non-integrating in nature, and degraded by normal cellular mechanisms

India's first mRNA Covid-19 vaccine moves to advanced clinical trials

Aug 25, 2021

mRNA-based vaccines got global focus following the huge success of Pfizer BioNTech and Fosun Pharma's Covid-19 vaccine Comirnaty (BNT162b2) and US-based Moderna's Covid-19 vaccine mRNA-1273

The study was based on data from more than 1.2 million test results

Protection from Pfizer, AstraZeneca COVID-19 vaccines wane within 6 Months: UK Study

Aug 25, 2021

After five to six months, the effectiveness of the Pfizer jab at preventing COVID-19 infection in the month after the second dose fell from 88% to 74%, an analysis of data collected in Britain's ZOE COVID study showed